OAM
RVPH

Oxford Asset Management’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Oxford Asset Management’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-13,505
Closed -$2.83M – 1089
2019
Q4 		$2.83M Sell
13,505
-5,010
-27% -$1.05M 0.08% 265
2019
Q3 		$3.83M Hold
18,515
– – 0.09% 251
2019
Q2 		$3.88M Hold
18,515
– – 0.08% 347
2019
Q1 		$3.74M Hold
18,515
– – 0.08% 290
2018
Q4 		$3.65M Buy
+18,515
New +$3.63M 0.09% 228

Other funds holding RVPH

Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MSU
Mizuho Securities USA New York $6.2B AUM 35.46% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
BI
Bulldog Investors Saddle Brook, New Jersey $445M AUM 2.55% 1-Year Est. Return

Oxford Asset Management's RVPH Position: Q1 2020 in Review

Oxford Asset Management sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q1 2020, closing a stake of 13,505 shares — an estimated $2.83M sold.

Oxford Asset Management first reported a position in RVPH in Q4 2018 and held it in 5 quarters. The position peaked at $3.88M in Q2 2019. 24 funds tracked by Wall St. Rank hold RVPH as of Q1 2020.

  • Oxford Asset Management reported no remaining REVIVA PHARMA HLDGS INC position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 13,505 REVIVA PHARMA HLDGS INC shares in Q1 2020, an estimated $2.83M.
  • Oxford Asset Management first reported a position in REVIVA PHARMA HLDGS INC in Q4 2018 and held it in 5 quarters.
  • Oxford Asset Management's REVIVA PHARMA HLDGS INC position peaked at $3.88M in Q2 2019.
  • 24 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.